Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

Overview

Study to learn if the alternate formulation is effective in agitated schizophrenic patients

Study Type

  • Study Type: Interventional
  • Study Design
    • Primary Purpose: Treatment
  • Study Primary Completion Date: January 2003

Interventions

  • Drug: aripiprazole

Participating in This Clinical Trial

Inclusion Criteria

  • Agitated schizophrenic patients

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Otsuka Pharmaceutical Development & Commercialization, Inc.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.